Profil
Joseph Catanese is the founder of NeoTract, Inc., which was founded in 2004.
He holds the title of Vice President-Operations & Innovation at NeoTract, Inc. Dr. Catanese is currently the Chief Executive Officer at Calyxo, Inc. Dr. Catanese's former job was as an Engineer-Research & Development at TransVascular, Inc. He also worked as a Manager-Product Development at Medtronic Vascular, Inc. Dr. Catanese's education includes an undergraduate degree from Cornell University and a doctorate degree from the University of California, Berkeley.
Aktive Positionen von Joseph Catanese
| Unternehmen | Position | Beginn |
|---|---|---|
NeoTract, Inc.
 NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | Gründer | 01.01.2004 |
Calyxo, Inc.
 Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Joseph Catanese
| Unternehmen | Position | Ende |
|---|---|---|
TransVascular, Inc.
 TransVascular, Inc. Medical SpecialtiesHealth Technology Transvascular (TVI) is a development stage medical device company that is definig a new class of intervention for the treatment of vascular diseases and other disorders. Unlike conventional therapies that are limited to treatment within blood vessels, the company's novel therapeutic approach extends beyond the vessel boundaries | Corporate Officer/Principal | - |
| Medtronic Vascular, Inc. | Corporate Officer/Principal | - |
Ausbildung von Joseph Catanese
| Cornell University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | Health Technology |
| Medtronic Vascular, Inc. | |
TransVascular, Inc.
TransVascular, Inc. Medical SpecialtiesHealth Technology Transvascular (TVI) is a development stage medical device company that is definig a new class of intervention for the treatment of vascular diseases and other disorders. Unlike conventional therapies that are limited to treatment within blood vessels, the company's novel therapeutic approach extends beyond the vessel boundaries | Health Technology |
Calyxo, Inc.
Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA. | Health Technology |
